India gets world’s first once-a-week insulin: All about Novo Nordisk’s Awiqli | India News
Awiqli is a long-acting basal insulin designed to provide steady background insulin support throughout the week. India has become one of the first countries in the world to introduce Awiqli, the world’s first once-a-week basal insulin approved for clinical use, offering a new treatment option for adults living with diabetes.The launch comes at a crucial…